Home › Drugs › Pluvicto › Cost and coverage

Pluvicto cost and insurance coverage: a plain-language guide

By CSE Team · Last updated: October 15, 2026

Hearing that Pluvicto (lutetium Lu 177 vipivotide tetraxetan) could help is hopeful news. Then the money questions arrive: Will insurance cover it? What will we owe? Who do we even call? This guide walks you and your family through how Pluvicto is usually billed, what Medicare and private insurance tend to cover, and where to find help, so cost doesn't have to be the thing that keeps you up at night.

ℹ️ General information to help you and your loved ones talk with your care team, not medical advice. Read our disclaimer.

Why Pluvicto is billed differently from pills

Pluvicto is a radioligand therapy (a radiation medicine that seeks out cancer cells). Each dose is shipped to a nuclear medicine department and given by IV, usually once every 6 weeks for up to 6 doses, according to the FDA label. Because a care team gives it to you, it falls under the part of Medicare that Medicare.gov describes as covering drugs you wouldn't usually give yourself, such as those given in a doctor's office or hospital outpatient department. That's Part B. Private insurers usually handle it under the medical benefit too, though plans differ.

This matters for two reasons. Medical benefits often use coinsurance (a percentage of the cost) rather than a flat copay, and many plans require prior authorization (approval before treatment) before the first dose.

What "reimbursement" means for you

If you've searched for Pluvicto reimbursement, you may have landed on pages written for clinics. Reimbursement is how the treatment center gets paid by your insurer. For you, it shows up as your share of the bill: your deductible, coinsurance, or copay. The center's financial counselor or billing office is the best person to estimate your share before the first dose. Questions worth asking:

• Has my insurance approved Pluvicto, and is the approval for each dose or for the whole course?
• What will I likely owe per dose, and for the full course?
• Are the PSMA PET scan, lab tests, and visit fees billed separately?
• Is this center in my plan's network?
• Can you help me apply to Novartis Patient Support or a foundation grant?

If you have Medicare

Under Original Medicare, after you meet the yearly Part B deductible, you usually pay up to 20% of the Medicare-approved amount for Part B drugs. Medicare.gov also notes that providers must accept assignment for Part B-covered drugs, so they shouldn't ask you to pay more than your coinsurance or copayment for the drug itself. For a costly treatment, 20% can still be a lot, so it's worth checking what else can help:

• A Medicare Supplement (Medigap) plan, retiree coverage, or Medicaid may pay part or all of that 20%.
• Medicare Advantage plans set their own cost sharing and often require prior authorization, but they also have a yearly limit on what you pay for covered medical care.
• Manufacturer co-pay programs can't be used with Medicare, so look at independent foundations that help.
• Read more in our guide to Medicare and your cancer drugs.

If you have private or job-based insurance

Novartis offers a Pluvicto co-pay program for people with private insurance. According to the program terms Novartis posts online (checked October 26, 2026), eligible patients may get help with up to $15,000 in out-of-pocket costs for the drug over the course of treatment. It isn't valid with Medicare, Medicaid, TRICARE, VA, or other government programs, and Novartis can change the terms at any time.

Novartis also reports that, in its review of insurance claims from early 2023 to mid-2024, about 85% of covered patients paid $0 out of pocket for the medicine per infusion. Costs varied for the rest, and other treatment-related costs, such as administration fees, can still apply. Keep in mind this is the maker's own data, not a promise about your plan.

Novartis Patient Support

Novartis Patient Support can help find a treatment center, check your insurance, work through prior authorization, and look at financial options, and it pairs you with a patient navigator. You can call 1-844-638-7222, Monday to Friday, 8 AM to 8 PM ET (excluding holidays), or sign up online. Your care team often starts the paperwork for you.

If you have no insurance, or your plan won't cover Pluvicto, ask your navigator and the Novartis Patient Assistance Foundation whether you might qualify for other help.

Costs beyond the medicine

• Imaging: a PSMA PET scan before treatment to confirm the cancer has enough PSMA, and later scans to see how it's working.
• Lab tests: blood counts and kidney tests before and during treatment, as the label recommends.
• Travel: Pluvicto is given only at centers that can handle radioactive medicines, which may be far from home. The American Cancer Society's Road To Recovery offers free rides to treatment in some areas, and Hope Lodge offers free lodging near some cancer centers.
• Time at home: after each dose, the label advises limiting close contact with others for several days. Plan childcare, sleeping arrangements, and time off ahead. Our Pluvicto (lutetium Lu 177 vipivotide tetraxetan) guide has the details.

If insurance says no

• Ask your oncologist to request a peer-to-peer review, a call with the insurer's doctor to explain why you need Pluvicto.
• Appeal in writing. The denial letter explains how and by when; deadlines matter.
• Ask Novartis Patient Support for help with the paperwork.
• Keep notes on every call: the date, the person's name, and a reference number.

Questions people often ask

Written by the CSE Team from FDA labels and leading cancer centers. Not medical advice. · Last updated: October 15, 2026 · How we write